North America Therapeutic Vaccines Market

North America Therapeutic Vaccines Market Size (2023 to 2028)

The North America Therapeutic Vaccines Market is set to reach USD 11.869.61 Million by 2028 from USD 5705.93 Million in 2023, with a CAGR of 15.78% during the forecast period.

North America is estimated to dominate the global temperature management market from 2023 to 2028 and even accounted for the largest market share in 2021. The market growth in this region is majorly supported by factors such as an increase in the volume of surgical procedures, a growing elder people population, increasing the occurrence rate of cardiac arrest, and nerve disorders. Moreover, advanced technological products like battery-powered devices and standalone, which bolster the temperature management market in this region. U.S and Canada are the two major contributors to this region.

The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features that increase the complexity of assessing and understanding pricing and procurement in their context.

Increase in funding’s from the government for vaccine development, rise in investments by the major market players, rising prevalence of the disease, technological advancements, initiatives by NGOs are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies and high costs associated with treatment are few factors inhibiting the market's growth.

This research report on the North America Therapeutic Vaccines Market segmented and sub-segmented into the following categories:

By Disease Type:

• Autoimmune Disease
• Cancer
• Neurological Disease
  • Parkinson's Disease Vaccine
  • Alzheimer's Disease Vaccine
• Infectious Disease
  • Hepatitis C
  • HIV/AIDS
  • Others

By Country:

• The United States
• Canada
• Rest of North America

Geographically, the United States therapeutic vaccines market is anticipated to register the highest market share in the North American market during the forecast period. There is a high demand for cosmetic surgeries in the United States coupled with the acquisitions of technologically advanced patient warming and cooling systems, rising number of government funds in improving healthcare infrastructure are significantly boosting the market in the United States.

The Canadian therapeutic vaccines market is expected to witness a healthy CAGR during the forecast period. Favorable reimbursement policies, the existence of major key players, a frequent increase of chronic diseases, and low-cost surgeries are accelerating Canada's growth during the analysis period.

Some of the prominent companies leading the North America Therapeutic Vaccines Market Profiled in the Report are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.